PeptiDream Inc 4587
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4587 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- JPY 1,962.00
- Day Range
- JPY 1,890.50–1,971.00
- 52-Week Range
- JPY 1,039.00–2,549.00
- Bid/Ask
- JPY 1,944.50 / JPY 1,954.00
- Market Cap
- JPY 253.19 Bil
- Volume/Avg
- 752,000 / 937,647
Key Statistics
- Price/Earnings (Normalized)
- 54.38
- Price/Sales
- 8.87
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.20%
Company Profile
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 603
- Website
- http://www.peptidream.com
Comparables
Valuation
|
Metric
|
4587
|
4563
|
4893
|
|---|---|---|---|
Price/Earnings (Normalized) | 54.38 | — | — |
Price/Book Value | 6.30 | 0.37 | 1.17 |
Price/Sales | 8.87 | 60.63 | 20.16 |
Price/Cash Flow | 158.48 | — | — |
Price/Earnings
4587
4563
4893
Financial Strength
|
Metric
|
4587
|
4563
|
4893
|
|---|---|---|---|
Quick Ratio | 2.84 | 1.68 | 65.18 |
Current Ratio | 3.16 | 2.38 | 66.28 |
Interest Coverage | 2.85 | — | — |
Quick Ratio
4587
4563
4893
Profitability
|
Metric
|
4587
|
4563
|
4893
|
|---|---|---|---|
Return on Assets (Normalized) | 4.49% | −16.00% | −19.85% |
Return on Equity (Normalized) | 8.24% | −19.90% | −20.61% |
Return on Invested Capital (Normalized) | 7.81% | −19.26% | −20.61% |
Return on Assets
4587
4563
4893
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hmytycxlv | Qhjq | $567.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dkzsyjc | Nqfwxy | $109.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Btvgvnlg | Vgpqkyg | $105.3 Bil | |
MRNA
| Moderna Inc | Wzwbfdpc | Bmsq | $47.0 Bil | |
ARGX
| argenx SE ADR | Cvyfyvbz | Fgjk | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Pqtsdzpbk | Mgj | $22.1 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Xfmbsbz | Jtpwjm | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jdshqqcsp | Qjhbfsm | $15.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Nlsftdkhs | Hzbhpfq | $12.7 Bil | |
INCY
| Incyte Corp | Mptdvsr | Gvvdq | $12.0 Bil |